EichorEICHOR
Study identifier: NCT04205812 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Condition: Metastatic Squamous Non-Small Cell Lung Cancer · Metastatic Nonsquamous Non-Small Cell Lung Cancer  ·  Sponsor: Incyte Corporation

PhasePhase 3
Planned participants583
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC).

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (140)

Pacific Cancer Medical CenterAnaheim, California, United States
Innovative Clinical Research InstituteWhittier, California, United States
Reading Hospital and Medical CenterReading, Pennsylvania, United States
Fundacao Pio Xii Hospital de Cancer de BarretosBarretos, Brazil
Incan - Instituto Do Cancer - Hospital PompeiaCaxias do Sul, Brazil
Centro Regional Integrado de OncologiaFortaleza, Brazil
Oncosite - Centro de Pesquisa Clinica E OncologiaIjuí, Brazil
Clinica de Neoplasias Litoral LtdaItajaí, Brazil
Hospital Do Cancer de LondrinaLondrina, Brazil
Instituto Mederi de Pesquisa E SaudePasso Fundo, Brazil
Hgb - Hospital Giovanni Battista - Mae de Deus CenterPorto Alegre, Brazil
Inca - Instituto Nacional de CancerRio de Janeiro, Brazil

+ 128 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →